Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: David E. Kandzari October 30, 2016 REGISTER for free or LOG IN to view this content Clinical Cardiology Presentation TCT 2016 Hypertension Up Next Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Justin E. Davies October 30, 2016 More slides + Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Martin B. Leon October 30, 2016 Presentation TCT 2016 Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Presenter: Wilko Spiering October 30, 2016 We Recommend
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Justin E. Davies October 30, 2016
Presentation TCT 2016 Why are These Trials Recruiting Slowly and How Can We Improve Recruitment Rates? Presenter: Martin B. Leon October 30, 2016
Presentation TCT 2016 Carotid Barostimulation to Treat Hypertension (Vascular Dynamics): Mobius HD and the CALM Studies Presenter: Wilko Spiering October 30, 2016